![US economy adds fewer jobs than expected in August, increasing odds of 50bp cut](https://i-invdn-com.investing.com/news/moved_small-LYNXMPEH970O1_L.jpg)
Please try another search
Name | Net % | Long % | Short % |
---|---|---|---|
Cash | 0.340 | 0.500 | 0.160 |
Stocks | 99.660 | 99.660 | 0.000 |
Ratios | Value | Category Average |
---|---|---|
P/E Ratio | 19.874 | 20.274 |
Price to Book | 2.993 | 3.993 |
Price to Sales | 3.711 | 4.971 |
Price to Cash Flow | 14.221 | 16.434 |
Dividend Yield | 1.118 | 0.472 |
5 Years Earnings Growth | 7.588 | 12.964 |
Number of long holdings: 106
Number of short holdings: 25
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
Alnylam | US02043Q1076 | 3.31 | 247.78 | -1.47% | |
Vertex | US92532F1003 | 3.18 | 469.86 | +0.28% | |
Amgen | US0311621009 | 3.12 | 320.89 | -1.07% | |
Novartis | CH0012005267 | 3.08 | 98.60 | -0.31% | |
Biomarin Pharma | US09061G1013 | 3.04 | 84.74 | -0.45% | |
Ionis Pharma | US4622221004 | 3.02 | 47.35 | -1.67% | |
Gilead | US3755581036 | 3.02 | 78.47 | -0.37% | |
Biogen | US09062X1037 | 2.97 | 199.56 | -1.11% | |
Roche Holding Participation | CH0012032048 | 2.96 | 273.70 | -0.91% | |
Crispr Therapeutics | CH0334081137 | 2.91 | 44.38 | -1.92% |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
JPI Global Income Fund C acc USD he | 17.44B | 8.52 | 2.16 | 4.52 | ||
Global Income Fund D div USD hedged | 17.44B | 7.77 | 1.11 | 3.46 | ||
JPI Global Income Fund C mth USD he | 17.44B | 6.45 | 1.77 | 4.41 | ||
JPI Global Income Fund D acc USD he | 17.44B | 7.78 | 1.13 | 3.48 | ||
JPI Global Income Fund D mth USD he | 17.44B | 5.79 | 0.71 | 3.36 |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review